Similar articles

• Nitrogen mustard therapy of pediatric nephrotic syndrome.

  Tune BM, Mendoza SA. Tune BM, et al. Pediatr Nephrol. 1996 Feb;10(1):131. doi: 10.1007/BF00863470. Pediatr Nephrol. 1996. PMID: 8611345 No abstract available.
• Nitrogen mustard therapy in idiopathic nephrotic syndrome of childhood.

  Broyer M, Meziane A, Kleinknecht C, Niaudet P. Broyer M, et al. Int J Pediatr Nephrol. 1985 Jan-Mar;6(1):29-34. Int J Pediatr Nephrol. 1985. PMID: 3997369
• Nitrogen mustard therapy in children with frequent-relapsing nephrotic syndrome and steroid toxicity.

  Schoeneman MJ, Spitzer A, Greifer I. Schoeneman MJ, et al. Am J Kidney Dis. 1983 Mar;2(5):526-9. doi: 10.1016/s0272-6386(83)80094-8. Am J Kidney Dis. 1983. PMID: 6829569
• Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome.

  Ponticelli C, Passerini P. Ponticelli C, et al. Nephrol Dial Transplant. 1991;6(6):381-8. doi: 10.1093/ndt/6.6.381. Nephrol Dial Transplant. 1991. PMID: 1876280 Review. No abstract available.
• Alkylating agents in the treatment of nephrotic syndrome.

  West CD. West CD. Perspect Nephrol Hypertens. 1973;1 Pt 1:199-210. Perspect Nephrol Hypertens. 1973. PMID: 4620919 Review. No abstract available.